Nuwellis, Inc. (NUWE)

Market Cap	4.09M
Revenue (ttm)	8.74M
Net Income (ttm)	-10.62M
Shares Out	4.37M
EPS (ttm)	-8.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,030
Open	0.9055
Previous Close	0.8920
Day's Range	0.9055 - 0.9110
52-Week Range	0.7500 - 14.0000
Beta	0.51
Analysts	Strong Buy
Price Target	17.00 (+1,719.16%)
Earnings Date	May 6, 2025

About NUWE

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Aus...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: NUWE
• Website: https://www.nuwellis.com

Financial Performance

In 2024, Nuwellis's revenue was $8.74 million, a decrease of -1.40% compared to the previous year's $8.86 million. Losses were -$10.62 million, -53.05% less than in 2023.

Analyst Forecast

According to one analyst, the rating for NUWE stock is "Strong Buy" and the 12-month stock price forecast is $17.0.

Price Target

$17.0

(1,719.16% upside)

Analyst Consensus: Strong Buy